Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results-Reference-Cited by-同舟云学术

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results

Published:1998-12 Issue:6 Volume:28 Page:964-975
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Isner Jeffrey M.,Baumgartner Iris,Rauh Guenter,Schainfeld Robert,Blair Richard,Manor Orit,Razvi Syed,Symes James F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference27 articles.

1. Buerger's disease (thromboangiitis obliterans);Shionoya,1995

2. Thromboangiitis obliterans (Buerger's disease);Olin,1996

3. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease);Olin;Circulation,1990

4. Nonatherosclerotic segmental arterial occlusion of the extremity;Inada;Arch Surg,1974

5. Enhanced revascularization of the ischemic limb by means of angiogenic therapy;Pu;Circulation,1993

Cited by 343 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells;Biomedicines;2024-07-06

2. Role of endothelial Raptor in abnormal arteriogenesis after lower limb ischaemia in type 2 diabetes;Cardiovascular Research;2024-05-09

3. Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine;Biomedicine & Pharmacotherapy;2023-10

4. Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans;Annals of Medicine;2023-06-15

5. E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model;Cardiovascular Therapeutics;2023-05-19